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Hydrogen peroxideCytochrome bd is a prokaryotic respiratory quinol:O2 oxidoreductase, phylogenetically unrelated to the exten-
sively studied heme–copper oxidases (HCOs). The enzyme contributes to energy conservation by generating a
proton motive force, though working with a lower energetic efﬁciency as compared to HCOs. Relevant to
patho-physiology, members of the bd-family were shown to promote virulence in some pathogenic bacteria,
which makes these enzymes of interest also as potential drug targets. Beyond its role in cell bioenergetics,
cytochrome bd accomplishes several additional physiological functions, being apparently implicated in the
response of the bacterial cell to a number of stress conditions. Compelling experimental evidence suggests that
the enzyme enhances bacterial tolerance to oxidative and nitrosative stress conditions, owing to its unusually
high nitric oxide (NO) dissociation rate and a notable catalase activity; the latter has been recently documented
in one of the two bd-type oxidases of Escherichia coli. Current knowledge on cytochrome bd and its reactivitywith
O2, NO and H2O2 is summarized in this review in the light of the hypothesis that the preferential (over HCOs)
expression of cytochrome bd in pathogenic bacteria may represent a strategy to evade the host immune attack
based on production of NO and reactive oxygen species (ROS). This article is part of a Special Issue entitled:
18th European Bioenergetic Conference.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Cytochrome bd oxidase [1–3] is a respiratory oxidase conﬁned to the
prokaryoticworld (Eubacteria andArchaea), phylogenetically unrelated
to the extensively studied protein family of heme–copper oxidases
(HCOs) [4–7]. Similarly to HCOs, this integral membrane protein cata-
lyzes the complete, four-electron reduction of O2 to 2H2O, using quinols
as physiological reducing substrates [2] (Fig. 1). The overall reaction is
electrogenic [8], resulting in the generation of a proton motive force
across themembrane that is used for ATP synthesis by the ATP synthase
[8–12]. The reaction, however, is not coupled to proton pumping [9] and
it is therefore characterized by a lower energetic efﬁciency, as compared
toHCOs. At variance fromHCOs, cytochrome bddoes not contain copper,ic oxide; ROS, reactive oxygen
,3-dimethoxy-5-methyl-6-(3-
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ights reserved.but only three hemes as cofactors: two b-type hemes (hemes b558
and b595) and a heme d, where O2 and other gaseous ligands (carbon
monoxide (CO) and NO) bind (Fig. 1). The enzyme is reportedly charac-
terized by high afﬁnity for O2 and, accordingly, it is preferentially
expressed at low O2 tension.
Relevant to patho-physiology, cytochrome bd oxidase is expressed
in a number of bacterial pathogens. These include Salmonella [13,14],
Mycobacterium tuberculosis [15], Shigella ﬂexneri [16], Streptococcus
[17], Listeria monocytogenes [18], Brucella [19,20], members of the strict
anaerobe Bacteroides class [21] and Klebsiella pneumoniae [22]. Surpris-
ingly, in some of these pathogens, virulence was shown to depend on
cytochrome bd expression, pointing to a role of the enzyme in facilitat-
ing bacterial survival during infection. In M. tuberculosis, for example,
cytochrome bdwas reported to be up-regulated in vivo in the transition
from acute to chronic infection of mouse lungs, promoting bacterial
virulence: consistently, attenuated virulencewas observed for amutant
strain unable to express cytochrome bd [15]. Similarly, in Brucella
abortusmutation of cytochrome bdwas found to affect pathogen surviv-
al in a mouse machrophage-like cell line and bacterial virulence in
mouse models [19]. Very similar observations have been reported also
for S. ﬂexneri, where both intracellular survival and virulence were
interestingly even shown to positively correlate with cytochrome bd
expression levels [16]. All together, this evidence strongly suggests
that the bd-type oxidases are required for adaptation to host immunity,
Fig. 1. Schematic representation of cytochrome bd. The enzyme catalyzes the reduction of O2 to 2H2O, using quinol as the reducing substrate. The reaction is electrogenic, but it is not
coupled to proton pumping. In addition, a catalase activity was reported for cytochrome bd-I from E. coli [61]. The small protein CydX is required for the function of the enzyme and
has been proposed to be an additional subunit of the complex [28,29].
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also as drug targets.
Numerous observations suggest that, beyond its role in cell bioener-
getics, cytochrome bd accomplishes several additional physiological
functions in the bacterial cell. Serving as an O2-scavenger, the enzyme
favours the colonization of O2-poor environments inside the host by
both pathogenic and non-pathogenic bacteria [15,20,21,23]. It facilitates
the growth of anoxygenic bacterial phototrophs in a wider range of
ambient O2 concentrations [24] and it prevents the inactivation of O2-
sensitive enzymes (such as nitrogenase in diazotrophic bacteria)
(see refs. [3,25] and references therein). In E. coli, cytochrome bd-I1
was shown to act as a source of oxidizing power, thus enabling disulﬁde
bond formation byDsbA–DsbBduringprotein folding [26], and allowing
the action of protoporphyrinogen IX oxidase (HemG) in heme biosyn-
thesis [27]. Moreover, the enzyme seems to be also implicated in the
response of the bacterial cell to a number of stress conditions, such as
high temperature, high pH, membrane de-energization by uncouplers,
low O2 concentrations and metals or poisons in the medium (see refs.
[3,25] and references therein).
In addition to these functions, growing evidence supports the idea
that cytochrome bd plays a role in protecting the bacterial cell also
against oxidative and nitrosative stress conditions, i.e., against the
negative effects produced by O2, NO and related reactive species.
Given that these species are produced as part of the host immune
response to control microbial infections, this evidence contributes to
elucidate the mechanism by which cytochrome bd promotes bacterial
virulence.2. The reaction with O2
Cytochrome bd is composed of two integral membrane polypeptides,
subunits I (CydA, 57 kDa) and II (CydB, 43 kDa), and a small protein,
named CydX (4 kDa), that has been recently found to be important
for the enzymatic activity and proposed to be an additional subunit
of the complex [28,29] (Fig. 1). The enzyme contains three heme
cofactors: the low spin hexacoordinate heme b558 and the high spin
pentacoordinate hemes b595 and d [30] (Fig. 1). Although three-
dimensional structures of cytochrome bd are still lacking, studies of
the protein topology in the membrane suggest that all the three
hemes are located near the periplasmic space. This implies that the
generation of the membrane potential mainly results from proton1 E. coli possesses the heme-copper cytochrome bo3 quinol oxidase and two bd-type ox-
idases, called bd-I and bd-II. Unless otherwise stated,we refer to cytochrome bd-I through-
out the manuscript.transfer from the cytoplasm towards the active site on the opposite
site of the membrane (Fig. 1), rather than from inter-heme electron
transfer. Heme b558 in subunit I is involved in quinol oxidation, whereas
heme d is the site where O2 binds and is reduced to H2O. The function of
heme b595 is still unclear. This redox site has been proposed to form
together with heme d a functional binuclear active site [10,31–38],
somewhat similarly to the heme/copper O2-reducing site in HCOs.
This hypothesis is supported by spectroscopic studies showing that
the Fe to Fe distance between hemes b595 and d is 10 Å [39].
Cytochrome bd and HCOs apparently share the same key intermedi-
ates of the catalytic cycle, as revealed by ﬂow-ﬂash [40] investigation of
the reaction of fully (three-electron) reduced cytochrome bd (R3 2)with
O2. In these studies, the reaction was monitored by spectroscopic
and electrometric techniques [8,10–12,41], following laser photolysis
of the CO-bound R3 enzyme in the presence of O2. Fig. 2 illustrates
the detected intermediates. The unliganded R3 enzyme promptly
generated upon CO-photolysis binds O2 very rapidly, forming the
species A3 with ferrous-oxy heme d. Formation of A3 occurs at high
rates (kon ~ 2 × 109 M−1 s−1 [11,41,42]) without generating electric
potential [8,11]. Afterwards, a rapid non-electrogenic oxidation of heme
b595 was observed. The resulting short-lived species, originally denoted
as P, was discovered at 21 °C by microsecond time-resolved absorption
spectroscopy and electrometry [11,12]. It was suggested [11,12] that
this is either a true peroxy complex or a ferryl species with an amino
acid radical or a porphyrin π-cation radical. Later, by investigating the re-
action at 1 °C by ultra-fast freeze-quench trapping combined with elec-
tron paramagnetic resonance (EPR) and UV–visible spectroscopy, Paulus
et al. [43] reported that P is a ferryl porphyrin π-cation radical intermedi-
ate. Accordingly, P was renamed as F*. Therefore, in this intermediate,
splitting of the O_O bond seems to have already occurred as a result
of a four-electron transfer process: three of these electrons are thought
to be donated by heme b595 (1 electron, Fe2+ ➔ Fe3+) and heme d (2
electrons, Fe2+➔ Fe4+), whereas the fourth electron is supposedly pro-
vided by the heme d porphyrin ring, thus forming a radical. It is worthy
to note, however, that some concern still remains on whether the P in-
termediate observed in [11,12] is actually the same as F*measured at
lower temperature in [43]. Further work may be required to clarify the
precise chemical structure of this transient species. In the reaction of bo-
vine cytochrome c oxidase (CcO) with O2, a ferryl intermediate resem-
bling F* in the bd oxidase [43] is populated, that anyway for historical
reasons was named ‘P’ (as incorrectly assigned to a peroxo-species)
(see [44] and references therein): in the CcO intermediate, however,
the radical does not reside on the porphyrin ring, as suggested for2 The superscript number denotes the total number of electrons in the enzyme species.
Fig. 2. Catalytic cycle. Catalytic intermediates populated in the reaction of fully reduced enzyme with O2. In each intermediate, the superscript number denotes the total number of elec-
trons in the enzyme and theheme redox state is indicated by open (Fe3+) and closed (Fe2+) circles. The F and F* intermediates contain heme d in the Fe4+ state. In the F* intermediate, the
asterisk denotes a radical on the heme d porphyrin ring. The intermediates detected at steady state [50] are highlighted.
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tyrosine that is close to the O2 binding site. In cytochrome bd, upon elec-
tron transfer from heme b558, F* converts into the F intermediate, which
has the same ferryl structure but no radical. The transition to F is electro-
genic and proceeds with τ= 47 μs [8,10–12]. In the presence of bound
quinol(s) copurifying with the enzyme, F is converted into O or, more
likely, into the single-electron reduced, oxygenated enzyme (A1), since
quinol can act as a two-electron donor. This last step of the reaction is
electrogenic and proceeds with τ= 0.6–1.1 ms [10,11].Fig. 3. Steady-state occupancy of the catalytic intermediates. Fractional occupancy of the
optical species detected at steady-state after stopped-ﬂow mixing reduced cyochrome
bdwith O2-equilibrated buffer (see [50] for details). Concentrations after mixing: 10 μM
enzyme, 5 mM DTT and 300 μM Q1. T = 20 °C. Reprinted from [50] with permission
from Elsevier.Differently from HCOs, to which O2 can only bind at the heme–
copper binuclear site in the two-electron (fully) reduced state [45],
cytochrome bd can bind O2 with high afﬁnity as a single electron
reduced species (R1), yielding A1 with ferrous-oxy heme d. Due to the
high stability of A1, a substantial fraction of the enzyme is isolated in
such a state [42,46,47]. As measured by ﬂow-ﬂash technique, O2 binds
to R1 cytochrome bdwith rates hyperbolically dependent on O2 concen-
tration [42]. In contrast, as expected for a bimolecular process assayed
under pseudo-ﬁrst order conditions, O2 binds to the R3 enzyme with
rates linearly dependent on O2 concentration [42]. As a tentative expla-
nation for the different behaviour, it has been proposed that the R1
enzyme exists in two different conformations that are in equilibrium,
one O2-accessible (‘open’) and the other O2-inacessible (‘closed’) [42].
Consistently, also in the case of CO, the R3 cytochrome bd binds and re-
leases the ligand more rapidly than the R1 enzyme [38,41,48,49]. The
redox state of the heme(s) b, therefore, clearlymodiﬁes the ligand bind-
ing properties of heme d. However, both the structural determinants of
this redox control and its possible mechanistic relevance remain to be
assessed.
Taking advantage of the remarkable optical differences between
the heme d and the b-type hemes in cytochrome bd, the steady-state
occupancy of the catalytic O2 intermediates in the enzymewasmeasured
by stopped-ﬂow multiwavelength absorption spectroscopy [50]. Global
analysis of the spectral data acquired after rapidly mixing reduced
cytochrome bd with O2-equilibrated buffer in the presence of excess
DTT (dithiothreitol) and Q1 (2,3-dimethoxy-5-methyl-6-(3-methyl-2-
butenyl)-1,4-benzoquinone) showed that the catalytic intermediates
mostly populated at steady-state are the ferryl (F) and oxy-ferrous
(A) species, with a residual minor fraction of the enzyme possibly in
Fig. 4. Cytochrome bd catalase activity. A) O2 evolution measured after addition of 1 mM
H2O2 to the puriﬁed E. coli cytochrome bd-I in turnover with 10 mM DTT and 250 μM
Q1. B) Catalase activity observed after addition of 235 μM H2O2 to respiring katE/katG-
deﬁcient E. coli cells over-expressing cytochrome bd (trace 1). O2 evolution is much less pro-
nounced after addition of H2O2 to the same catalase deﬁcient strain not over-expressing
cytochrome bd (trace 2). Reprinted from [61] with permission from Elsevier.
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(Fig. 3). These results are consistent with the proposal that the fully
ferric O species is not a catalytic intermediate [51]. Notably, different
results were obtained with CcO, using cytochrome c as the reducing
substrate: for this enzyme the steady-state occupancy of the oxygen
catalytic intermediates was reported to be very low (b10%, [52]).
3. Cytochrome bd and oxidative stress
Several lines of evidence point to a role of cytochrome bd in bacterial
protection against oxidative stress. In E. coli, for example, mutants
defective in cytochrome bd display increased levels of intracellular
H2O2 [53], as inferred from the enhanced expression of the gene coding
for KatG catalase, also known as HPI. Consistently, these mutants show
an increased sensitivity to external H2O2 [53,54], although conﬂicting
results were also reported more recently [29]. Along the same line,
defects in E. coli cytochrome bd are associated to characteristic pheno-
types, including higher temperature-sensitivity and defects in station-
ary phase growth, that were interestingly found to be corrected upon
treatment with reducing agents or exogenous antioxidant enzymes,
such as catalase and superoxide dismutase [55]. Moreover, expression
of E. coli cytochrome bd increases when bacterial cells are exposed to
external H2O2 [53], again pointing to a defence role of the enzyme
against oxidative stress. It is also interesting that such a role does not
seem to be unique to cytochrome bd from E. coli. In the Gram-negative
diazotrophic bacterium A. vinelandii, for example, mutation of cyto-
chrome bd also results in a hypersensitivity to H2O2, metals (Cu2+ and
Zn2+) and other compounds exerting oxidative stress, such as paraquat
and plumbagin [56]. In line with these observations, it was recently
reported that disruption of cytochrome cmaturation inM. tuberculosis
results in the overexpression of cytochrome bd oxidase along with a
hyper-resistance of the bacterium to H2O2 [57,58]. Particularly interest-
ing is also the case of Brucella abortus, in which the lack of cytochrome
bd expression is associated not only with an increased sensitivity to
H2O2 [19,28], but also with a reduced bacterial virulence in a murineinfection model, and both effects were shown to completely revert
upon bacterial transformation with a vector harbouring genes encoding
catalase or superoxide dismutase [19]. All together, these observations
suggest that, in addition to their bioenergetic role, bd-type oxidases
from several bacterial sources are also able to afford protection against
oxidative stress, and this may represent an advantage particularly
for pathogenic bacteria that have to cope with the hostile oxidative
conditions created by the immune system in response to microbial
infection.
Despite this large body of evidence, the molecular mechanisms by
which cytochrome bd enhances bacterial resistance to oxidative stress
are not completely understood. Two non-mutually exclusive possibili-
ties can be envisaged: cytochrome bdmay act by reducing the produc-
tion of intracellular H2O2 and other ROS, and/or by metabolizing these
species. The former possibility has been repeatedly suggested based
on the notion that the enzyme, due to its high afﬁnity for O2, is expected
to reduce the intracellular O2 level, and thus ROS formation. Along the
same line, more recently it was suggested that, in E. coli, cytochrome
bd can act as an electron sink and decrease electrons availability for
fumarate reductase, an important source of H2O2, thereby diminishing
the rate of H2O2 formation by this enzyme when anaerobic cultures
are exposed to O2 [59]. As outlined above, in addition to these possibil-
ities, cytochrome bdmay act by directly removing H2O2 and other ROS.
In support of this hypothesis, a lowperoxidase activitywas documented
for E. coli cytochrome bd-I [60] and, more recently, Borisov et al. [61]
reported the unprecedented observation that the same enzymedisplays
high catalase activity (Fig. 1).
Experimental evidence for the catalase activity of E. coli cytochrome
bd-I was obtained by monitoring the increase in the O2 concentration,
following the addition of H2O2 to the enzyme, either puriﬁed or
overexpressed in a catalase-deﬁcient E. coli strain (Fig. 4) [61]. A
remarkable activity was observed with the puriﬁed enzyme both in
the ‘as isolated’ state and in turnover with O2 sustained by an excess
of reductants (DTT and Q1). O2 concentration was not found to have
an effect on this catalase activity; however, intriguingly, no activity
was measured following full reduction of the enzyme by DTT and Q1
under anaerobic conditions [61]. As expected, the activity proportional-
ly increased with the enzyme concentration and disappeared after
thermal denaturation of the enzyme. Surprisingly, the catalase activity
was found not to compete with the O2-reducing activity of the enzyme
[61], suggesting that the H2O2 chemistry takes place at a site other than
heme d, where O2 binds and reacts. Consistently, heme d-targeting
inhibitors, such as CO or NO, proved to be unable to inhibit the catalase
activity of E. coli cytochrome bd-I, though preventing the reaction with
O2. The observed insensitivity to NO strongly argues against the idea
that the catalase activity of cytochrome bd arises from a contaminant
bona ﬁde catalase, as the latter enzyme is strongly inhibited by NO. In
agreement with this conclusion, the activity was observed also in an
E. coli strain devoid of both katE and katG genes, following overexpres-
sion of cytochrome bd-I (Fig. 4) [61].
Yet far from being elucidated, the molecular mechanism underlying
the cytochrome bd catalase activity remains elusive. Assays with inhib-
itors have ruled out that the catalytic decomposition of H2O2 involves
thiol groups or the quinol-binding site of the enzyme [61]. On the
other hand, the catalase activity proved to be ~1000-times more sensi-
tive to cyanide than the O2-reducing activity of the enzyme: cyanide
inhibition of the catalase activity indeed occurs with Ki ~ 2.5 μM,where-
as the O2-reducing activity of the enzyme is known to be inhibited only
at millimolar cyanide concentrations [62]. The high cyanide sensitivity
points to the involvement of a heme in the catalase reaction of E. coli
cytochrome bd-I, that Borisov et al. [61] tentatively proposed to be
heme b595. However, based on the ﬁnding that cyanide added at a
concentration sufﬁcient to completely inhibit the catalase activity
induces minimal spectral changes in the isolated protein, it was
suggested that only a minor fraction (4% or less) of the puriﬁed enzyme
is catalytically competent in metabolizing H2O2 [61].
Fig. 5. Reversible inhibition of cytochrome bd and CcO by NO. A) Oxygraphic traces show-
ing NO inhibition of E. coli cytochrome bd-I and CcO, and activity recovery after addition of
oxy-haemoglobin (HbO2) to scavenge free NO. The recovery is remarkably faster in cyto-
chrome bd as compared to CcO. B) Kinetics of NO dissociation from fully reduced
NO-bound E. coli cytochrome bd-I and CcO,measured after mixing the NO-bound proteins
with air-equilibrated buffer in the presence of oxy-myoglobin in excess over the oxidases
(see [116] and [48] for details). NO dissociation is much faster in cytochrome bd than in
CcO.
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mostly puriﬁed in a state devoid of catalase activity, along with a
sub-population of the enzyme exhibiting a high catalase activity. Both
enzyme populations seem to co-exist in E. coli cells, although it is yet
unknown i) in which respect one enzyme population differs from the
other one from a structural point of view, ii) whether conversion
between the two populations is allowed and, iii) if this is the case,
how this process is controlled in living cells. At this stage, it is unknown
whether bd-type cytochromes from bacterial sources other than E. coli
are also endowed with a catalase activity, which represents an impor-
tant task for future studies. In this regard, it may be worth mentioning
that a reduced catalase activity was measured in cell extracts of
A. vinelandii by comparing a cytochrome bd-mutant with the wild-
type strain [56]. This ﬁnding could be indicative of a catalase activity
associated with the cytochrome bd from A. vinelandii, though this
remains to be demonstrated.
The unprecedented observation that E. coli cytochrome bd-I displays
high catalase activitymay acquire patho-physiological relevance, partic-
ularly if such activity is common to bd-type oxidases from other patho-
genic bacteria. Notably, it provides a reasonable mechanistic basis for
theﬁnding that these enzymes enhance bacterial resistance to oxidative
stress, as a possible strategy to evade the host immune response and
thus increase bacterial virulence.4. Cytochrome bd and nitrosative stress
During evolution, microorganisms have developed a number of
strategies to detoxify NO and survive nitrosative stress. NO and related
reactive species, produced from either abiotic or biotic sources, are
indeed commonly found in the natural habitats of prokaryotes, and
are also generated as part of the immune response to controlmicrobial infections. Infectious bacteria have, therefore, to cope
with nitrosative stress to enhance their pathogenicity. NO-reductases
and NO-dioxygenases (O2-denitrosylases), such as the NO-reductase
ﬂavorubredoxin [63,64] and the ﬂavohemoglobin [65,66] in E. coli, are
mainly responsible for NO detoxiﬁcation in microbes. The former
enzymes anaerobically reduce NO to dinitrogen oxide (N2O), while
NO-dioxygenases degrade NO to nitrate (NO3−), using O2 as co-
substrate. Flavohemoglobin is typically characterized by a relatively
low apparent afﬁnity for O2 (KM ~ 20–100 μM O2, [67–69]): though
promptly scavengingNOunder aerobic conditions, the enzyme is there-
fore much less efﬁcient under microaerobic conditions.
NO is a pleiotropic signalling molecule. Over and above controlling
numerous physiological and pathological processes, such as vasodila-
tion, platelet aggregation, neuromodulation, cell death and host immu-
nity, NO is also an effective inhibitor of HCOs (reviewed in [70–76]). As
shown by extensive studies on CcO, the enzyme is potently and rapidly
inhibited by sub-micromolar NO concentrations, with important patho-
physiological consequences (reviewed in [72–79]). Inhibition occurs
even in the presence of O2 in excess (over NO), but it reverts if NO in
solution is degraded. Two different reaction pathways have been dem-
onstrated for CcO inhibition by NO (reviewed in [70–76]): the ‘nitrosyl
pathway’ in which NO binds to ferrous heme a3 in the active site, yield-
ing a stable nitrosyl adduct, and the ‘nitrite pathway’, where a nitrite-
adduct of ferric heme a3 is generated by the reaction of NOwith enzyme
species containing fully oxidized heme a3/CuB or ferryl heme a3. While
the nitrosyl pathway occurs simply through the binding/release of
NO to/from ferrous heme a3, the nitrite pathway was proposed to
follow a multi-step mechanism, involving the transient formation of
nitrosonium ion (NO+) upon reaction of NO with oxidized CuB, and
its subsequent hydroxylation to nitrous acid/nitrite [80–83]. The O2-
competitive nitrosyl pathway prevails at higher electron ﬂux and
lower O2 concentration, whereas the nitrite pathway at lower electron
ﬂux and higher O2 concentration [84]. Both inhibition pathways are
reversible; however, in the absence of free NO in solution activity recov-
ery occurs with notably different kinetics in the two cases. The nitrosyl
enzyme recovers activity slowly, at the rate of NO dissociation form
ferrous heme a3 (k = 0.0035 s−1 at 20 °C, [84]) (Fig. 5) whereas, in
the case of nitrite-bound CcO, activity is promptly recovered following
the fast ejection of nitrite from heme a3 upon reduction of this site [85].
Similarly to CO [86] and O2 [42,47], in bd-type oxidases, NO binds to
ferrous heme dwith high afﬁnity, leading to formation of a tight nitrosyl
adduct with characteristic UV–visible absorption and EPR spectra
[87,88]. Hemes b595 [87,88] and b558 [35] in the reduced state were
also proposed to bind NO, but only at high, non-physiological ligand
concentrations. The kinetics of NO binding to the ferrous uncomplexed
heme d has not been investigated yet; the reaction is anyway expected
to be very fast, possibly proceeding at a rate comparable to thatmeasured
for O2 binding to the enzyme in the R3 state (kon ~ 2 × 109 M−1 s−1
[11,41,42]). Ferrous heme d in the A1 oxy-intermediate (Fe2+–O2) also
reacts with NO, yielding the nitrosyl heme d adduct, as a result of O2
displacement and subsequent NO binding to the heme; in this case, how-
ever, the reactionwas shown to be rate-limited by the off-rate of O2 from
the reduced heme (k=78 s−1 at 20 °C, [48]) (Fig. 6).Working on the en-
zyme puriﬁed from A. vinelandii, fast (k = 1.2 ± 0.1 × 105 M−1 s−1 at
20 °C) reaction of NO with the F intermediate was also documented
[89], yielding nitrite bound at ferric heme d (Fig. 6). It is yet unclear
whether the reaction occurs through the direct reaction of NOwith ferryl
heme d iron, as reported for myoglobin and haemoglobin [90,91], or in-
volving heme b595 too. The reaction of NO with the F intermediate was
previously shown to occur at a lower rate (k ~ 1–2 × 104 M−1 s−1) in
CcO, where CuB in the active site was suggested to be the primary site
of the reaction [82,83]. Based on the results obtained on the Cu-lacking
cytochrome bd, one may conclude that CuB is dispensable or possibly
not involved at all in the reaction. On the contrary, CuB seems to play
an important role in the reaction of NO with ferric heme in the fully oxi-
dized (O) active site of terminal oxidases, when comparing the results
Fig. 6. Reactions of heme d with NO. Ferrous and ferryl heme d reacts with NO quickly, yielding a nitrosyl ferrous (Fe2+–NO) or a nitrite–ferric (Fe3+–NO2−) derivative, respectively.
Reaction of NO with oxy-ferrous heme d is rate-limited by the dissociation of O2. Ferric heme d reacts with NO, yielding a nitrosyl ferric (Fe3+–NO↔ Fe2+–NO+) adduct.
1183A. Giuffrè et al. / Biochimica et Biophysica Acta 1837 (2014) 1178–1187obtained with the Cu-lacking cytochrome bd [92] with those achieved
with CcO [80,81]. In CcO, the reaction of NO with the fully oxidized en-
zyme is fast (k = 2.2 × 105 M−1 s−1 at 20 °C, [81]), unless chloride is
bound at the oxidized heme a3–CuB site [81], and was proposed to pro-
ceed through the oxidation of NO to nitrosonium ion (NO+) at CuB,
followed by hydroxylation of NO+ to nitrous acid/nitrite, eventually
binding to ferric heme a3 [80]. In contrast, regardless of chloride being
present, NO reacts with cytochrome bd in the O state at a much lower
rate (k= 1.5 ± 0.2 × 102 M−1 s−1 at 20 °C), yielding a nitrosyl adduct
(heme d2+-NO+ or heme d3+-NO), rather than the nitrite-bound
enzyme [92] (Fig. 6).
Summing up, several catalytic intermediates of cytochrome bd are
reactive towards NO: some of them just bind NO, while others seem
to be able to oxidatively degrade it into nitrite. This raises the question
as to whether bd-type oxidases are also able to reductivelymetabolize
nitrite (to NO) or NO (to N2O). Nitrite was reported to react with
reduced cytochrome bd in membrane particles of E. coli only very
slowly [93]. As for NO reduction, it is of interest that some bacterial
HCOs [94–96], but not mitochondrial CcO [97], can function as
NO-reductases at low rates, which may be consistent with the notion
that HCOs are believed to share a common phylogenesis with heme
b3-containing bacterial NO-reductases [98,99]. Differently from these
enzymes, however, neither cytochrome bd-I puriﬁed from E. coli nor
the homologous enzyme isolated from Azotobacter vinelandii proved
to be endowedwith a measurable NO reductase activity in amperomet-
ric experiments carried out under anaerobic conditions making use of a
selective NO electrode [100].Further experimental work aimed at testingwhether NO is an inhib-
itor of bd-type oxidases, as shown for CcO. The ﬁrst evidence that this is
actually the case was provided working on E. coli mutant cells lacking
the heme-copper cytochrome bo3 quinol oxidase, and measuring the
sensitivity of the residual cytochrome bd-mediated respiration to NO
[101]. This ﬁnding was later conﬁrmed and expanded by measuring
the effect of NO on the O2 consumption catalyzed by cytochrome bd
isolated from E. coli or A. vinelandii in the presence of DTT and Q1
[100]. In this study, relatively low amounts (≤1 μM) of NOwere report-
ed to completely inhibit each one of the two bd-type oxidases [100]
(Fig. 5A), further demonstrating that the presence of CuB is not essential
for terminal oxidases inhibition by NO. For E. coli cytochrome bd-I, the
IC50 value measured for NO inhibition (100 ± 34 nM at 70 μM O2
[100]) is comparable to that reported for CcO [102,103]. Possibly rele-
vant to microbial physiology, the inhibition was found to be stronger
at lower O2 concentrations. In experiments carried out on cytochrome
bo3-lacking E. coli cells, an IC50 linearly dependent on [O2]wasmeasured
(at least up to ~150 μM O2), showing that NO inhibition of cytochrome
bd is set in competitionwith O2 [104]. Onemay therefore expect that, in
host infecting bacteria, inhibition of cytochrome bd is likely to occur
when these microorganisms colonize O2-poor environments and are
challenged by the relatively high concentrations (μM) of NO produced
by the host immune system as a defence against microbial infection.
The molecular mechanism by which NO inhibits cytochrome bd in
turnover with O2 is still a matter of debate. The O2-competitive nature
of NO inhibition [100,104] suggests that NO targets one ormore enzyme
species with uncomplexed heme d2+, that are clearly reactive with O2
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afﬁnity of heme d2+ for NO. On the other hand, if NO was reacting
only with heme d2+, at low [NO]:[O2] ratios the onset of inhibition
should be relatively slow; both ligands are indeed expected to bind
heme d2+ with comparable rate constants, and O2 present in large
molar excess would therefore outcompete NO binding to heme d2+.
This is however in conﬂict with the observation that, even in the pres-
ence of a large excess of O2 (100–200 μM), the enzyme is inhibited
quickly by relatively low NO concentrations (≤1 μM), as observed also
for CcO. To account for this discrepancy, one may hypothesize that,
similarly to CcO, when the enzyme is in turnover, one or more catalytic
intermediates without ferrous uncomplexed heme d2+ are populated
that, in spite of their low or even absent reactivity towards O2, are
promptly targeted by NO, resulting in enzyme inhibition. The hypothe-
sis is supported by the recent observation that the O2-unreactive
oxy-ferrous (A) and ferryl (F) intermediates, both able to react with
NO, are the main catalytic intermediates populated at steady-state
[50] (Fig. 3).
Regardless of the exact mechanism by which cytochrome bd is
inhibited by NO, it is interesting to notice that, following the removal
of NO from solution, in cytochrome bd activity is notably restored
much more rapidly than in CcO under similar experimental condi-
tions [84,100] (Fig. 5A). In the case of CcO, under high electron ﬂux
conditions, reversal of inhibition proceeds at the low rate of NO dissoci-
ation from ferrous heme a3 (k = 0.0035 s−1 at 20 °C, [84]). Since
NO-inhibited cytochrome bd is likely to contain a similar nitrosyl
Fe2+-NO heme d adduct, the faster release of NO inhibition of the
enzyme should result from a faster release of NO from ferrous heme d,
compared to CcO. The off-rate of the ligand from heme d was thus
measured for both the fully reduced (R3-NO) and single-electron
reduced enzyme (R1-NO) by stopped-ﬂow absorption spectroscopy
[48]. Experiments were carried out mixing NO-bound cytochrome
bd with air-equilibrated buffer in the presence of an excess of oxy-
myoglobin, acting as both a trap and an optical indicator of the NO
released from heme d2+ after displacement by O2. Two interesting
results were obtained in this study. Firstly, the off-rate of NO from
heme d in fully reduced cytochrome bd was found to be remarkably
higher than in CcO (k = 0.133 s−1 vs k = 0.0035 s−1, [48,84])
(Fig. 5B), possibly accounting for the faster release of NO inhibition
observed in the case of cytochrome bd [100]. CO dissociation from the
bacterial enzyme also proved to be remarkably faster than that from
the mitochondrial enzyme (k = 6.0 ± 0.2 s−1 vs k = 0.023 s−1
[40,48]), supporting the view that CuB in HCOs controls the on/off
ligand pathway to/from the nearby heme in the active site [105].
Secondly, a clear effect of the redox state of the b-type hemes on the
measured rateswas observed,withNOdissociating fromR3 cytochrome
bd more quickly than from the R1 enzyme (k = 0.133 ± 0.005 and
0.036 ± 0.003 s−1) [48].
The rate of NO dissociation from E. coli cytochrome bdwasmeasured
also in cell suspensions more recently [104] and found to be similar
(0.163 s−1 at 35 °C) to that one (0.133 s−1 at 20 °C) reported previously
for the puriﬁed fully reduced enzyme [48]. To be noted that the
NO off-rate measured for cytochrome bd is unusually high for a
hemeprotein: it is comparable to the NO dissociation rate reported for
soluble guanylate cyclase in the presence of GTP (k= 0.18 s−1, [106]),
but much lower than the rate more recently measured for cd1-type
nitrite reductases (up to 200 s−1, [107]). The fast release of NO from
reduced cytochrome bd should result from structural peculiarities of
heme d and/or its pocket that hopefully will be unveiled when the
three-dimensional structure of the enzyme will be solved.
Based on the information reported above, our groups proposed
[48,108] that, owing to their high NO off-rates, bd-type oxidases could
be preferentially expressed in place of HCOs to enhance bacterial toler-
ance to nitrosative stress, and possibly promote bacterial pathogenicity
(reviewed in [109]). Under NO stress conditions, the expression of a fast
NO-dissociating cytochrome bd instead of HCOs can indeed allow afaster recovery of bacterial respiration after NO inhibition, in response
to a decline in the NO ﬂux, and a reduced sensitivity of respiration to
NO, if the higher NO off-rate of the bd enzyme results into higher IC50
values for NO. This hypothesis was substantiated more recently by
Mason et al. [104] who reported that, in E. coli, compared to the
heme–copper bo3-type oxidase, cytochrome bd is less sensitive to
NO-inhibition, i.e., it is characterized by higher IC50 values for NO.
Consistently, compared to cytochrome bo3-deﬁcient E. coli cells, in
cytochrome bd-lacking cells NO induced a more severe growth inhibi-
tion [104]. In agreement with these results, recently cytochrome bd
has been shown to confer the facultative Gram-negative anaerobe
Shewanella oneidensis resistance to nitrite and NO during aerobic
growth [110,111].
All together, this information suggests that the preferential expres-
sion of cytochrome bd (over HCOs) may represent a general strategy
to enhance bacterial tolerance to nitrosative stress, a strategy that bac-
terial pathogens may utilize to evade the host immune attack based
on NO production. In this light, it is of interest that, according to a
transcriptomic analysis performed on chemostat-cultured E. coli [112],
upon exposure to NO, expression of the cytochrome bd genes proved
to be preferentially stimulated, whereas unaltered expression of the
cytochrome bo3 oxidase was observed. Notably, E. coli is not the only
system in which stimulation of cytochrome bd expression was docu-
mented, as NO-induced expression of cytochrome bd-related genes
was also reported forM. tuberculosis [15], Staphylococcus aureus [113],
Bacillus subtilis [114] and Desulfovibrio gigas [115].
5. Conclusions and future perspectives
Growing evidence suggests that cytochrome bd enhances bacterial
tolerance to oxidative and nitrosative stress conditions. This ability
seems relevant particularly for pathogenic bacteria, as hostile condi-
tions of this type are typically created as part of the immune response
to ﬁght microbial infection. This leads to the hypothesis that, by en-
abling survival under oxidative and nitrosative stress, cytochrome bd
expression represents a strategy for pathogenic bacteria to evade
the immune attack and thus enhance bacterial virulence, as already
documented for speciﬁc pathogens. In this regard, cytochrome bd
oxidases are to be considered as potential drug targets.
Studies on cytochrome bd unveiled functional peculiarities,
apparently not shared by the better known HCOs, that suitably account
for the protective role played by this enzyme against oxidative and
nitrosative stress. Extensive studies on the reactivity of NO with the
catalytic intermediates of cytochrome bd led to the discovery that the
enzyme, though being inhibited by NO, exhibits an unusually fast
NO dissociation rate from the active site, unlike HCOs and most
hemeproteins. This high dissociation rate results in a fast activity recov-
ery of the NO-inhibited enzyme upon NO removal from solution and,
possibly, in a reduced sensitivity of the enzyme to NO inhibition. More-
over, a recent study revealed that a cytochrome bd (the bd-I oxidase
from E. coli), both isolated and overexpressed in bacterial cells, exhibits
a high catalase activity, enabling prompt degradation of H2O2. We think
that this peculiar reactivity of cytochrome bd towardNOandH2O2 likely
emerged during evolution as an adaptive strategy to enhance bacterial
tolerance to oxidative and nitrosative stress conditions.
Despite these achievements, several questions remain to be
addressed. First of all, studies on bd-type oxidases need to be extended
to a wider range of bacteria, including a bigger set of pathogens, to
establish whether the unusual properties recently unveiled are charac-
teristic of these respiratory oxidases and correlate with bacterial patho-
genicity. More work is then needed in the future to elucidate the yet
obscure mechanism underlying the catalase activity shown by cyto-
chrome bd, and its control in the bacterial cell. It is unclear if such activ-
ity results from a conformational switch, from post-translational
modiﬁcations and/or assembly with additional polypeptides/proteins,
such as, for instance, the small protein CydX [28,29]. Finally, solving
1185A. Giuffrè et al. / Biochimica et Biophysica Acta 1837 (2014) 1178–1187the three-dimensional structure of the enzyme represents an important
goal also in the perspective of designing selective inhibitors of pharma-
cological interest.
Acknowledgements
This work was partially supported by Ministero dell'Istruzione,
dell'Università e della Ricerca of Italy (FIRB RBFR08F41U_001 to A.G.,
FIRB RBIN06E9Z8 and PRIN 2008FJJHKM_002 to P.S.) and by the
Russian Foundation for Basic Research (grant 14-04-00153-a to V.B.B.).
References
[1] V.B. Borisov, Cytochrome bd: structure and properties, Biochem. Mosc. 61 (1996)
565–574(translated from Biokhimiya (in Russian) (1996), 61, 1786–1799).
[2] S. Jünemann, Cytochrome bd terminal oxidase, Biochim. Biophys. Acta 1321 (1997)
107–127.
[3] V.B. Borisov, R.B. Gennis, J. Hemp, M.I. Verkhovsky, The cytochrome bd respiratory
oxygen reductases, Biochim. Biophys. Acta 1807 (2011) 1398–1413.
[4] M. Brunori, A. Giuffrè, P. Sarti, Cytochrome c oxidase, ligands and electrons, J. Inorg.
Biochem. 99 (2005) 324–336.
[5] M.M. Pereira, F.L. Sousa, A.F. Verissimo, M. Teixeira, Looking for the minimum
common denominator in haem-copper oxygen reductases: towards a uniﬁed cat-
alytic mechanism, Biochim. Biophys. Acta 1777 (2008) 929–934.
[6] P. Brzezinski, R.B. Gennis, Cytochrome c oxidase: exciting progress and remaining
mysteries, J. Bioenerg. Biomembr. 40 (2008) 521–531.
[7] O.M. Richter, B. Ludwig, Electron transfer and energy transduction in the terminal
part of the respiratory chain — lessons from bacterial model systems, Biochim.
Biophys. Acta 1787 (2009) 626–634.
[8] A. Jasaitis, V.B. Borisov, N.P. Belevich, J.E. Morgan, A.A. Konstantinov, M.I.
Verkhovsky, Electrogenic reactions of cytochrome bd, Biochemistry 39 (2000)
13800–13809.
[9] A. Puustinen, M. Finel, T. Haltia, R.B. Gennis, M. Wikström, Properties of the two
terminal oxidases of Escherichia coli, Biochemistry 30 (1991) 3936–3942.
[10] I. Belevich, V.B. Borisov, J. Zhang, K. Yang, A.A. Konstantinov, R.B. Gennis, M.I.
Verkhovsky, Time-resolved electrometric and optical studies on cytochrome bd
suggest a mechanism of electron–proton coupling in the di-heme active site,
Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3657–3662.
[11] I. Belevich, V.B. Borisov, M.I. Verkhovsky, Discovery of the true peroxy intermediate
in the catalytic cycle of terminal oxidases by real-time measurement, J. Biol. Chem.
282 (2007) 28514–28519.
[12] V.B. Borisov, I. Belevich, D.A. Bloch, T. Mogi, M.I. Verkhovsky, Glutamate 107 in
subunit I of cytochrome bd from Escherichia coli is part of a transmembrane
intraprotein pathway conducting protons from the cytoplasm to the heme
b595/heme d active site, Biochemistry 47 (2008) 7907–7914.
[13] L. Zhang-Barber, A.K. Turner, G. Martin, G. Frankel, G. Dougan, P.A. Barrow, Inﬂuence
of genes encoding proton-translocating enzymes on suppression of Salmonella
typhimurium growth and colonization, J. Bacteriol. 179 (1997) 7186–7190.
[14] A.K. Turner, L.Z. Barber, P. Wigley, S. Muhammad, M.A. Jones, M.A. Lovell, S. Hulme,
P.A. Barrow, Contribution of proton-translocating proteins to the virulence of
Salmonella enterica Serovars Typhimurium, Gallinarum, and Dublin in chickens
and mice, Infect. Immun. 71 (2003) 3392–3401.
[15] L. Shi, C.D. Sohaskey, B.D. Kana, S. Dawes, R.J. North, V. Mizrahi, M.L. Gennaro,
Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and
under in vitro conditions affecting aerobic respiration, Proc. Natl. Acad. Sci. U. S. A.
102 (2005) 15629–15634.
[16] S.S. Way, S. Sallustio, R.S. Magliozzo, M.B. Goldberg, Impact of either elevated or
decreased levels of cytochrome bd expression on Shigella ﬂexneri virulence,
J. Bacteriol. 181 (1999) 1229–1237.
[17] Y. Yamamoto, C. Poyart, P. Trieu-Cuot, G. Lamberet, A. Gruss, P. Gaudu, Respiration
metabolism of Group B Streptococcus is activated by environmental haem and
quinone and contributes to virulence, Mol. Microbiol. 56 (2005) 525–534.
[18] M.H. Larsen, B.H. Kallipolitis, J.K. Christiansen, J.E. Olsen, H. Ingmer, The response
regulator ResD modulates virulence gene expression in response to carbohydrates
in Listeria monocytogenes, Mol. Microbiol. 61 (2006) 1622–1635.
[19] S. Endley, D. McMurray, T.A. Ficht, Interruption of the cydB locus in Brucella abortus
attenuates intracellular survival and virulence in the mouse model of infection,
J. Bacteriol. 183 (2001) 2454–2462.
[20] S. Loisel-Meyer,M.P. Jimenez de Bagues, S. Kohler, J.P. Liautard, V. Jubier-Maurin, Dif-
ferential use of the two high-oxygen-afﬁnity terminal oxidases of Brucella suis for
in vitro and intramacrophagic multiplication, Infect. Immun. 73 (2005) 7768–7771.
[21] A.D. Baughn, M.H. Malamy, The strict anaerobe Bacteroides fragilis grows in and
beneﬁts from nanomolar concentrations of oxygen, Nature 427 (2004) 441–444.
[22] N.S. Juty, F. Moshiri, M. Merrick, C. Anthony, S. Hill, The Klebsiella pneumoniae
cytochrome bd' terminal oxidase complex and its role in microaerobic nitrogen
ﬁxation, Microbiology 143 (1997) 2673–2683.
[23] S.A. Jones, F.Z. Chowdhury, A.J. Fabich, A. Anderson, D.M. Schreiner, A.L. House, S.M.
Autieri, M.P. Leatham, J.J. Lins, M. Jorgensen, P.S. Cohen, T. Conway, Respiration of
Escherichia coli in the mouse intestine, Infect. Immun. 75 (2007) 4891–4899.
[24] B.K. Hassani, A.S. Steunou, S. Liotenberg, F. Reiss-Husson, C. Astier, S. Ouchane,
Adaptation to oxygen: role of terminal oxidases in photosynthesis initiation inthe purple photosynthetic bacterium, Rubrivivax gelatinosus, J. Biol. Chem. 285
(2010) 19891–19899.
[25] R.K. Poole, G.M. Cook, Redundancy of aerobic respiratory chains in bacteria?
Routes, reasons and regulation, Adv. Microb. Physiol. 43 (2000) 165–224.
[26] M. Bader, W. Muse, D.P. Ballou, C. Gassner, J.C.A. Bardwell, Oxidative protein fold-
ing is driven by the electron transport system, Cell 98 (1999) 217–227.
[27] K. Mobius, R. Arias-Cartin, D. Breckau, A.L. Hannig, K. Riedmann, R. Biedendieck, S.
Schroder, D. Becher, A. Magalon, J. Moser, M. Jahn, D. Jahn, Heme biosynthesis is
coupled to electron transport chains for energy generation, Proc. Natl. Acad. Sci.
U. S. A. 107 (2010) 10436–10441.
[28] Y.H. Sun, M.F. de Jong, A.B. den Hartigh, C.M. Roux, H.G. Rolan, R.M. Tsolis, The
small protein CydX is required for function of cytochrome bd oxidase in Brucella
abortus, Front. Cell. Infect. Microbiol. 2 (2012) 47.
[29] C.E. VanOrsdel, S. Bhatt, R.J. Allen, E.P. Brenner, J.J. Hobson, A. Jamil, B.M. Haynes,
A.M. Genson, M.R. Hemm, The Escherichia coli CydX protein is a member of the
CydAB cytochrome bd oxidase complex and is required for cytochrome bd oxidase
activity, J. Bacteriol. 195 (2013) 3640–3650.
[30] V.B. Borisov, M.I. Verkhovsky, Chapter 3.2.7, oxygen as acceptor, in: R.C.I.A. Bock,
J.B. Kaper, P.D. Karp, F.C. Neidhardt, T. Nystrom, J.M. Slauch, C.L. Squires, D.
Ussery (Eds.), EcoSal — Escherichia coli and Salmonella: Cellular and Molecular
Biology, ASM Press, Washington, DC, 2009, (bhttp://ecosal.org/oxygen-as-
acceptor.htmlN).
[31] J.J. Hill, J.O. Alben, R.B. Gennis, Spectroscopic evidence for a heme–heme binuclear
center in the cytochrome bd ubiquinol oxidase from Escherichia coli, Proc. Natl.
Acad. Sci. U. S. A. 90 (1993) 5863–5867.
[32] M. Tsubaki, H. Hori, T. Mogi, Y. Anraku, Cyanide-binding site of bd-type ubiquinol
oxidase from Escherichia coli, J. Biol. Chem. 270 (1995) 28565–28569.
[33] V.B. Borisov, R.B. Gennis, A.A. Konstantinov, Interaction of cytochrome bd
from Escherichia coli with hydrogen peroxide, Biochem. Mosc. 60 (1995)
231–239(translated from Biokhimiya (in Russian) (1995), 60, 1315–1327).
[34] M.H. Vos, V.B. Borisov, U. Liebl, J.-L. Martin, A.A. Konstantinov, Femtosecond reso-
lution of ligand–heme interactions in the high-afﬁnity quinol oxidase bd: a
di-heme active site? Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1554–1559.
[35] V. Borisov, A.M. Arutyunyan, J.P. Osborne, R.B. Gennis, A.A. Konstantinov, Magnetic
circular dichroism used to examine the interaction of Escherichia coli cytochrome
bd with ligands, Biochemistry 38 (1999) 740–750.
[36] V.B. Borisov, S.E. Sedelnikova, R.K. Poole, A.A. Konstantinov, Interaction of
cytochrome bd with carbon monoxide at low and room temperatures: evidence
that only a small fraction of heme b595 reacts with CO, J. Biol. Chem. 276 (2001)
22095–22099.
[37] V.B. Borisov, U. Liebl, F. Rappaport, J.-L. Martin, J. Zhang, R.B. Gennis, A.A.
Konstantinov, M.H. Vos, Interactions between heme d and heme b595 in quinol
oxidase bd from Escherichia coli: a photoselection study using femtosecond spec-
troscopy, Biochemistry 41 (2002) 1654–1662.
[38] F. Rappaport, J. Zhang, M.H. Vos, R.B. Gennis, V.B. Borisov, Heme–heme and heme–
ligand interactions in the di-heme oxygen-reducing site of cytochrome bd from
Escherichia coli revealed by nanosecond absorption spectroscopy, Biochim.
Biophys. Acta 1797 (2010) 1657–1664.
[39] A.M. Arutyunyan, V.B. Borisov, V.I. Novoderezhkin, J. Ghaim, J. Zhang, R.B. Gennis,
A.A. Konstantinov, Strong excitonic interactions in the oxygen-reducing site of
bd-type oxidase: the Fe-to-Fe distance between hemes d and b595 is 10 Å,
Biochemistry 47 (2008) 1752–1759.
[40] Q. Gibson, C. Greenwood, Reactions of cytochrome oxidase with oxygen and
carbon monoxide, Biochem. J. 86 (1963) 541–555.
[41] B.C. Hill, J.J. Hill, R.B. Gennis, The room temperature reaction of carbon monoxide
and oxygenwith the cytochrome bd quinol oxidase from Escherichia coli, Biochem-
istry 33 (1994) 15110–15115.
[42] I. Belevich, V.B. Borisov, D.A. Bloch, A.A. Konstantinov, M.I. Verkhovsky, Cyto-
chrome bd from Azotobacter vinelandii: evidence for high-afﬁnity oxygen binding,
Biochemistry 46 (2007) 11177–11184.
[43] A. Paulus, S.G. Rossius, M. Dijk, S. de Vries, Oxoferryl-porphyrin radical catalytic
intermediate in cytochrome bd oxidases protects cells from formation of reactive
oxygen species, J. Biol. Chem. 287 (2012) 8830–8838.
[44] G.T. Babcock, How oxygen is activated and reduced in respiration, Proc. Natl. Acad.
Sci. U. S. A. 96 (1999) 12971–12973.
[45] J.G. Lindsay, C.S. Owen, D.F. Wilson, The invisible copper of cytochrome c oxidase,
Arch. Biochem. Biophys. 169 (1975) 492–505.
[46] V.B. Borisov, I.A. Smirnova, I.A. Krasnosel'skaya, A.A. Konstantinov, Oxygenated
cytochrome bd from Escherichia coli can be converted into the oxidized form by
lipophilic electron acceptors, Biochem. Mosc. 59 (1994) 437–443(translated from
Biokhimiya (in Russian) (1994), 59, 1598–1606).
[47] I. Belevich, V.B. Borisov, A.A. Konstantinov, M.I. Verkhovsky, Oxygenated complex
of cytochrome bd from Escherichia coli: stability and photolability, FEBS Lett. 579
(2005) 4567–4570.
[48] V.B. Borisov, E. Forte, P. Sarti, M. Brunori, A.A. Konstantinov, A. Giuffrè, Redox
control of fast ligand dissociation from Escherichia coli cytochrome bd, Biochem.
Biophys. Res. Commun. 355 (2007) 97–102.
[49] S. Jünemann, J.M. Wrigglesworth, P.R. Rich, Effects of decyl-aurachin D and
reversed electron transfer in cytochrome bd, Biochemistry 36 (1997) 9323–9331.
[50] V.B. Borisov, E. Forte, P. Sarti, A. Giuffrè, Catalytic intermediates of cytochrome bd
terminal oxidase at steady-state: ferryl and oxy-ferrous species dominate, Biochim.
Biophys. Acta 1807 (2011) 503–509.
[51] K. Yang, V.B. Borisov, A.A. Konstantinov, R.B. Gennis, The fully oxidized form of the
cytochrome bd quinol oxidase from E. coli does not participate in the catalytic
cycle: direct evidence from rapid kinetics studies, FEBS Lett. 582 (2008)
3705–3709.
1186 A. Giuffrè et al. / Biochimica et Biophysica Acta 1837 (2014) 1178–1187[52] M.G. Mason, P. Nicholls, C.E. Cooper, The steady-state mechanism of cytochrome c
oxidase: redox interactions between metal centres, Biochem. J. 422 (2009)
237–246.
[53] A. Lindqvist, J. Membrillo-Hernandez, R.K. Poole, G.M. Cook, Roles of respiratory
oxidases in protecting Escherichia coli K12 from oxidative stress, Antonie Van
Leeuwenhoek 78 (2000) 23–31.
[54] D. Wall, J.M. Delaney, O. Fayet, B. Lipinska, T. Yamamoto, C. Georgopoulos,
arc-Dependent thermal regulation and extragenic suppression of the Escherichia
coli cytochrome d operon, J. Bacteriol. 174 (1992) 6554–6562.
[55] B.S. Goldman, K.K. Gabbert, R.G. Kranz, The temperature-sensitive growth and
survival phenotypes of Escherichia coli cydDC and cydAB strains are due to deﬁcien-
cies in cytochrome bd and are corrected by exogenous catalase and reducing
agents, J. Bacteriol. 178 (1996) 6348–6351.
[56] S.E. Edwards, C.S. Loder, G. Wu, H. Corker, B.W. Bainbridge, S. Hill, R.K. Poole,
Mutation of cytochrome bd quinol oxidase results in reduced stationary phase
survival, iron deprivation, metal toxicity and oxidative stress in Azotobacter
vinelandii, FEMS Microbiol. Lett. 185 (2000) 71–77.
[57] J.L. Small, S.W. Park, B.D. Kana, T.R. Ioerger, J.C. Sacchettini, S. Ehrt, Perturbation
of cytochrome c maturation reveals adaptability of the respiratory chain in
Mycobacterium tuberculosis, MBio 4 (2013)(e00475-00413).
[58] E. Forte, V.B. Borisov, A. Davletshin, D. Mastronicola, P. Sarti, A. Giuffrè, Cytochrome
bd oxidase and hydrogen peroxide resistance inMycobacterium tuberculosis, MBio
4 (2013) e01006–e01013.
[59] S. Korshunov, J.A. Imlay, Two sources of endogenous hydrogen peroxide in
Escherichia coli, Mol. Microbiol. 75 (2010) 1389–1401.
[60] V.B. Borisov, A.I. Davletshin, A.A. Konstantinov, Peroxidase activity of cytochrome
bd from Escherichia coli, Biochem. Mosc. 75 (2010) 428–436(translated from
Biokhimiya (in Russian) (2010), 75, 2520–2530).
[61] V.B. Borisov, E. Forte, A. Davletshin, D. Mastronicola, P. Sarti, A. Giuffrè, Cytochrome
bd oxidase from Escherichia coli displays high catalase activity: an additional
defense against oxidative stress, FEBS Lett. 587 (2013) 2214–2218.
[62] K. Kita, K. Konishi, Y. Anraku, Terminal oxidases of Escherichia coli aerobic respira-
tory chain. II. Puriﬁcation and properties of cytochrome b558-d complex from cells
grown with limited oxygen and evidence of branched electron-carrying systems,
J. Biol. Chem. 259 (1984) 3375–3381.
[63] A.M. Gardner, R.A. Helmick, P.R. Gardner, Flavorubredoxin, an inducible catalyst for
nitric oxide reduction and detoxiﬁcation in Escherichia coli, J. Biol. Chem. 277
(2002) 8172–8177.
[64] C.M. Gomes, A. Giuffrè, E. Forte, J.B. Vicente, L.M. Saraiva, M. Brunori, M. Teixeira, A
novel type of nitric-oxide reductase. Escherichia coli ﬂavorubredoxin, J. Biol. Chem.
277 (2002) 25273–25276.
[65] P.R. Gardner, A.M. Gardner, L.A. Martin, A.L. Salzman, Nitric oxide dioxygenase: an
enzymic function for ﬂavohemoglobin, Proc. Natl. Acad. Sci. U. S. A. 95 (1998)
10378–10383.
[66] A. Hausladen, A. Gow, J.S. Stamler, Flavohemoglobin denitrosylase catalyzes the
reaction of a nitroxyl equivalent with molecular oxygen, Proc. Natl. Acad. Sci.
U. S. A. 98 (2001) 10108–10112.
[67] A.M. Gardner, L.A. Martin, P.R. Gardner, Y. Dou, J.S. Olson, Steady-state and tran-
sient kinetics of Escherichia coli nitric-oxide dioxygenase (ﬂavohemoglobin). The
B10 tyrosine hydroxyl is essential for dioxygen binding and catalysis, J. Biol.
Chem. 275 (2000) 12581–12589.
[68] C.E. Mills, S. Sedelnikova, B. Soballe, M.N. Hughes, R.K. Poole, Escherichia coli
ﬂavohaemoglobin (Hmp) with equistoichiometric FAD and haem contents has a
low afﬁnity for dioxygen in the absence or presence of nitric oxide, Biochem. J.
353 (2001) 207–213.
[69] D. Mastronicola, F. Testa, E. Forte, E. Bordi, L.P. Pucillo, P. Sarti, A. Giuffrè,
Flavohemoglobin and nitric oxide detoxiﬁcation in the human protozoan parasite
Giardia intestinalis, Biochem. Biophys. Res. Commun. 399 (2010) 654–658.
[70] C.E. Cooper, Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector?
Trends Biochem. Sci. 27 (2002) 33–39.
[71] P. Sarti, A. Giuffrè, M.C. Barone, E. Forte, D. Mastronicola, M. Brunori, Nitric oxide
and cytochrome oxidase: reaction mechanisms from the enzyme to the cell, Free
Radic. Biol. Med. 34 (2003) 509–520.
[72] M. Brunori, E. Forte, M. Arese, D. Mastronicola, A. Giuffrè, P. Sarti, Nitric oxide and
the respiratory enzyme, Biochim. Biophys. Acta 1757 (2006) 1144–1154.
[73] C.E. Cooper, C. Giulivi, Nitric oxide regulation of mitochondrial oxygen consump-
tion II: molecular mechanism and tissue physiology, Am. J. Physiol. Cell Physiol.
292 (2007) C1993–C2003.
[74] P. Sarti, M. Arese, E. Forte, A. Giuffrè, D. Mastronicola, Mitochondria and nitric
oxide: chemistry and pathophysiology, Adv. Exp. Med. Biol. 942 (2012) 75–92.
[75] P. Sarti, E. Forte, A. Giuffrè, D. Mastronicola, M.C. Magniﬁco, M. Arese, The chemical
interplay between nitric oxide and mitochondrial cytochrome c oxidase: reactions,
effectors and pathophysiology, Int. J. Cell Biol. 2012 (2012) 571067.
[76] P. Sarti, E. Forte, D. Mastronicola, A. Giuffrè, M. Arese, Cytochrome c oxidase and ni-
tric oxide in action: molecular mechanisms and pathophysiological implications,
Biochim. Biophys. Acta 1817 (2012) 610–619.
[77] J.D. Erusalimsky, S. Moncada, Nitric oxide and mitochondrial signaling: from phys-
iology to pathophysiology, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2524–2531.
[78] C.T. Taylor, S. Moncada, Nitric oxide, cytochrome C oxidase, and the cellular
response to hypoxia, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 643–647.
[79] P. Sarti, Nitric Oxide in Human Health and Disease, ELS. John Wiley & Sons, Ltd.,
Chichester, April 2013, http://dx.doi.org/10.1002/9780470015902.a0003390.pub2.
[80] C.E. Cooper, J. Torres, M.A. Sharpe, M.T. Wilson, Nitric oxide ejects electrons from
the binuclear centre of cytochrome c oxidase by reacting with oxidised copper: a
general mechanism for the interaction of copper proteins with nitric oxide? FEBS
Lett. 414 (1997) 281–284.[81] A. Giuffrè, G. Stubauer, M. Brunori, P. Sarti, J. Torres, M.T. Wilson, Chloride bound to
oxidized cytochrome c oxidase controls the reaction with nitric oxide, J. Biol. Chem.
273 (1998) 32475–32478.
[82] J. Torres, C.E. Cooper, M.T. Wilson, A common mechanism for the interaction of
nitric oxide with the oxidized binuclear centre and oxygen intermediates of
cytochrome c oxidase, J. Biol. Chem. 273 (1998) 8756–8766.
[83] A. Giuffrè, M.C. Barone, D. Mastronicola, E. D'Itri, P. Sarti, M. Brunori, Reaction of
nitric oxide with the turnover intermediates of cytochrome c oxidase: reaction
pathway and functional effects, Biochemistry 39 (2000) 15446–15453.
[84] P. Sarti, A. Giuffrè, E. Forte, D. Mastronicola, M.C. Barone, M. Brunori, Nitric oxide
and cytochrome c oxidase: mechanisms of inhibition and NO degradation,
Biochem. Biophys. Res. Commun. 274 (2000) 183–187.
[85] J. Torres, M.A. Sharpe, A. Rosquist, C.E. Cooper, M.T. Wilson, Cytochrome c oxidase
rapidly metabolises nitric oxide to nitrite, FEBS Lett. 475 (2000) 263–266.
[86] V.B. Borisov, Interaction of bd-type quinol oxidase from Escherichia coli
and carbon monoxide: heme d binds CO with high afﬁnity, Biochem. Mosc.
73 (2008) 14–22(translated from Biokhimiya (in Russian) (2008), 73,
2018–2028).
[87] S. Jünemann, J.M. Wrigglesworth, Cytochrome bd oxidase from Azotobacter
vinelandii. Puriﬁcation and quantitation of ligand binding to the oxygen reduction
site, J. Biol. Chem. 270 (1995) 16213–16220.
[88] H. Hori, M. Tsubaki, T. Mogi, Y. Anraku, EPR study of NO complex of bd-type
ubiquinol oxidase from Escherichia coli, J. Biol. Chem. 271 (1996) 9254–9258.
[89] V.B. Borisov, E. Forte, P. Sarti, M. Brunori, A.A. Konstantinov, A. Giuffrè, Nitric oxide
reacts with the ferryl-oxo catalytic intermediate of the CuB-lacking cytochrome bd
terminal oxidase, FEBS Lett. 580 (2006) 4823–4826.
[90] S. Herold, F.-J.K. Rehmann, Kinetic and mechanistic studies of the reactions of
nitrogen monoxide and nitrite with ferryl myoglobin, J. Biol. Inorg. Chem. 6
(2001) 543–555.
[91] S. Herold, F.-J.K. Rehmann, Kinetic of the reactions of nitrogen monoxide and
nitrite with ferryl hemoglobin, Free Radic. Biol. Med. 34 (2003) 531–545.
[92] V.B. Borisov, E. Forte, A. Giuffrè, A. Konstantinov, P. Sarti, Reaction of nitric oxide
with the oxidized di-heme and heme-copper oxygen-reducing centers of terminal
oxidases: Different reaction pathways and end-products, J. Inorg. Biochem. 103
(2009) 1185–1187.
[93] F.T. Bonner, M.N. Hughes, R.K. Poole, R.I. Scott, Kinetics of the reactions of
trioxodinitrate and nitrite ions with cytochrome d in Escherichia coli, Biochim.
Biophys. Acta 1056 (1991) 133–138.
[94] A. Giuffrè, G. Stubauer, P. Sarti, M. Brunori, W.G. Zumft, G. Buse, T. Soulimane, The
heme-copper oxidases of Thermus thermophilus catalyze the reduction of nitric
oxide: evolutionary implications, Proc. Natl. Acad. Sci. U. S. A. 96 (1999)
14718–14723.
[95] E. Forte, A. Urbani, M. Saraste, P. Sarti, M. Brunori, A. Giuffrè, The cytochrome cbb3
from Pseudomonas stutzeri displays nitric oxide reductase activity, Eur. J. Biochem.
268 (2001) 6486–6491.
[96] C. Butler, E. Forte, F. Maria Scandurra, M. Arese, A. Giuffrè, C. Greenwood, P. Sarti,
Cytochrome bo(3) from Escherichia coli: the binding and turnover of nitric oxide,
Biochem. Biophys. Res. Commun. 296 (2002) 1272–1278.
[97] G. Stubauer, A. Giuffrè, M. Brunori, P. Sarti, Cytochrome c oxidase does not catalyze
the anaerobic reduction of NO, Biochem. Biophys. Res. Commun. 245 (1998)
459–465.
[98] J. van der Oost, A.P.N. deBoer, J.-W.L. deGier, W.G. Zumft, A.H. Stouthamer, R.J.M.
van Spanning, The heme-copper oxidase family consists of three distinct types of
terminal oxidases and is related to nitric oxide reductase, FEMS Microbiol. Lett.
121 (1994) 1–10.
[99] M. Saraste, J. Castresana, Cytochrome oxidase evolved by tinkering with denitriﬁ-
cation enzymes, FEBS Lett. 341 (1994) 1–4.
[100] V.B. Borisov, E. Forte, A.A. Konstantinov, R.K. Poole, P. Sarti, A. Giuffrè, Interaction of
the bacterial terminal oxidase cytochrome bd with nitric oxide, FEBS Lett. 576
(2004) 201–204.
[101] T.M. Stevanin, N. Ioannidis, C.E. Mills, S.O. Kim, M.N. Hughes, R.K. Poole,
Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration,
catalyzed by cytochromes bo' or bd, from nitric oxide, J. Biol. Chem. 275 (2000)
35868–35875.
[102] G.C. Brown, C.E. Cooper, Nanomolar concentrations of nitric oxide reversibly inhib-
it synaptosomal respiration by competing with oxygen at cytochrome oxidase,
FEBS Lett. 356 (1994) 295–298.
[103] M.G. Mason, P. Nicholls, M.T. Wilson, C.E. Cooper, Nitric oxide inhibition of res-
piration involves both competitive (heme) and noncompetitive (copper)
binding to cytochrome c oxidase, Proc. Natl. Acad. Sci. U. S. A. 103 (2006)
708–713.
[104] M.G. Mason, M. Shepherd, P. Nicholls, P.S. Dobbin, K.S. Dodsworth, R.K. Poole, C.E.
Cooper, Cytochrome bd confers nitric oxide resistance to Escherichia coli, Nat.
Chem. Biol. 5 (2009) 94–96.
[105] D.D. Lemon, M.W. Calhoun, R.B. Gennis, W.H. Woodruff, The gateway to the active
site of heme-copper oxidases, Biochemistry 32 (1993) 11953–11956.
[106] S.P. Cary, J.A. Winger, M.A. Marletta, Tonic and acute nitric oxide signaling through
soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP, Proc.
Natl. Acad. Sci. U. S. A. 102 (2005) 13064–13069.
[107] S. Rinaldo, K.A. Sam, N. Castiglione, V. Stelitano, A. Arcovito, M. Brunori, J.W. Allen,
S.J. Ferguson, F. Cutruzzolà, Observation of fast release of NO from ferrous d haem
allows formulation of a uniﬁed reaction mechanism for cytochrome cd nitrite
reductases, Biochem. J. 435 (2011) 217–225.
[108] E. Forte, V.B. Borisov, A.A. Konstantinov, M. Brunori, A. Giuffrè, P. Sarti, Cytochrome
bd, a key oxidase in bacterial survival and tolerance to nitrosative stress, Ital. J.
Biochem. 56 (2007) 265–269.
1187A. Giuffrè et al. / Biochimica et Biophysica Acta 1837 (2014) 1178–1187[109] A. Giuffrè, V.B. Borisov, D. Mastronicola, P. Sarti, E. Forte, Cytochrome bd oxidase
and nitric oxide: From reaction mechanisms to bacterial physiology, FEBS Lett.
586 (2012) 622–629.
[110] H. Fu, H. Chen, J. Wang, G. Zhou, H. Zhang, L. Zhang, H. Gao, Crp-dependent
cytochrome bd oxidase confers nitrite resistance to Shewanella oneidensis, Environ.
Microbiol. 15 (2013) 2198–2212.
[111] H. Zhang, H. Fu, J. Wang, L. Sun, Y. Jiang, L. Zhang, H. Gao, Impacts of nitrate and
nitrite on physiology of Shewanella oneidensis, PLoS One 8 (2013) e62629.
[112] S.T. Pullan, M.D. Gidley, R.A. Jones, J. Barrett, T.M. Stevanin, R.C. Read, J. Green, R.K.
Poole, Nitric oxide in chemostat-cultured Escherichia coli is sensed by Fnr and
other global regulators: unaltered methionine biosynthesis indicates lack of
S-nitrosation, J. Bacteriol. 189 (2007) 1845–1855.[113] A.R. Richardson, P.M. Dunman, F.C. Fang, The nitrosative stress response of
Staphylococcus aureus is required for resistance to innate immunity, Mol.
Microbiol. 61 (2006) 927–939.
[114] C.M. Moore, M.M. Nakano, T. Wang, R.W. Ye, J.D. Helmann, Response of Bacillus
subtilis to nitric oxide and the nitrosating agent sodium nitroprusside, J. Bacteriol.
186 (2004) 4655–4664.
[115] P. Machado, R. Felix, R. Rodrigues, S. Oliveira, C. Rodrigues-Pousada, Characteriza-
tion and expression analysis of the cytochrome bd oxidase operon from
Desulfovibrio gigas, Curr. Microbiol. 52 (2006) 274–281.
[116] A. Giuffrè, E. Forte, M. Brunori, P. Sarti, Nitric oxide, cytochrome c oxidase and
myoglobin: competition and reaction pathways, FEBS Lett. 579 (2005)
2528–2532.
